Suppr超能文献

脑蛋白水解物-I 通过抑制 p53/SAT1/ALOX15 信号通路抑制铁死亡改善 APP/PS1 小鼠认知功能障碍。

Cerebroprotein hydrolysate-I ameliorates cognitive dysfunction in APP/PS1 mice by inhibiting ferroptosis via the p53/SAT1/ALOX15 signalling pathway.

机构信息

Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China; Neurological Laboratory of Hebei Province, Shijiazhuang, Hebei, 050000, China.

Department of Neurology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei, 050000, China.

出版信息

Eur J Pharmacol. 2024 Sep 15;979:176820. doi: 10.1016/j.ejphar.2024.176820. Epub 2024 Jul 18.

Abstract

Ferroptosis, an iron-dependent lipid peroxidation-driven cell death pathway, has been linked to the development of Alzheimer's disease (AD). However, the role of ferroptosis in the pathogenesis of AD remains unclear. Cerebroprotein hydrolysate-I (CH-I) is a mixture of peptides with neurotrophic effects that improves cognitive deficits and reduces amyloid burden. The present study investigated the ferroptosis-induced signalling pathways and the neuroprotective effects of CH-I in the brains of AD transgenic mice. Seven-month-old male APPswe/PS1dE9 (APP/PS1) transgenic mice were treated with intraperitoneal injections of CH-I and saline for 28 days. The Morris water maze test was used to assess cognitive function. CH-I significantly improved cognitive deficits and attenuated beta-amyloid (Aβ) aggregation and tau phosphorylation in the hippocampus of APP/PS1 mice. RNA sequencing revealed that multiple genes and pathways, including ferroptosis-related pathways, were involved in the neuroprotective effects of CH-I. The increased levels of lipid peroxidation, ferrous ions, reactive oxygen species (ROS), and altered expression of ferroptosis-related genes (recombinant solute carrier family 7, member 11 (SLC7A11), spermidine/spermine N1-acetyltransferase 1 (SAT1) and glutathione peroxidase 4 (GPX4)) were significantly alleviated after CH-I treatment. Quantitative real-time PCR and western blotting were performed to investigate the expression of key ferroptosis-related genes and the p53/SAT1/arachidonic acid 15-lipoxygenase (ALOX15) signalling pathway. The p53/SAT1/ALOX15 signalling pathway was found to be involved in mediating ferroptosis, and the activation of this pathway was significantly suppressed in AD by CH-I. CH-I demonstrated neuroprotective effects against AD by attenuating ferroptosis and the p53/SAT1/ALOX15 signalling pathway, thus providing new targets for AD treatment.

摘要

铁死亡是一种依赖铁的脂质过氧化驱动的细胞死亡途径,与阿尔茨海默病(AD)的发生有关。然而,铁死亡在 AD 发病机制中的作用尚不清楚。脑蛋白水解液-I(CH-I)是一种具有神经营养作用的肽混合物,可改善认知缺陷并减少淀粉样蛋白负担。本研究探讨了 CH-I 诱导的铁死亡信号通路及对 AD 转基因小鼠脑的神经保护作用。将 7 月龄雄性 APPswe/PS1dE9(APP/PS1)转基因小鼠用腹腔注射 CH-I 和生理盐水处理 28 天。使用 Morris 水迷宫试验评估认知功能。CH-I 显著改善了 APP/PS1 小鼠的认知缺陷,并减轻了海马体中β-淀粉样蛋白(Aβ)聚集和 tau 磷酸化。RNA 测序显示,包括铁死亡相关途径在内的多个基因和途径参与了 CH-I 的神经保护作用。脂质过氧化、亚铁离子、活性氧(ROS)水平升高,以及铁死亡相关基因(溶质载体家族 7 成员 11(SLC7A11)、亚精胺/精脒 N1-乙酰转移酶 1(SAT1)和谷胱甘肽过氧化物酶 4(GPX4))的表达改变,在 CH-I 治疗后明显缓解。实时定量 PCR 和 Western blot 用于研究关键铁死亡相关基因的表达及 p53/SAT1/花生四烯酸 15-脂氧合酶(ALOX15)信号通路。发现 p53/SAT1/ALOX15 信号通路参与介导铁死亡,并且 CH-I 显著抑制了 AD 中的该通路的激活。CH-I 通过减轻铁死亡和 p53/SAT1/ALOX15 信号通路对 AD 发挥神经保护作用,为 AD 治疗提供了新的靶点。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验